Haemonetics Corp Mass
HAENASDAQStock · Data from SEC EDGAR 13F · Held by 9 of 87 tracked investors
Haemonetics Corp Mass at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation17
- Growth53
- Profitability63
- Quality74
- Debt70
- Stability89
- Nothing notable from the statements.
- !The stock is expensive: you pay 58 USD for 1 USD of annual earnings.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveFor 1 USD of annual earnings you pay 58.0 USD. Based on next year's estimates 20.8 USD.
- P/E
- 58.0×
- P/S
- 4.0×
- EV/EBITDA
- 17.9×
Is the company growing?
Growing slowlyRevenue over 3 years grew 4.5% a year. Last year 5.6%.
Does it make money?
WeakEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 6 Aug 2026 | 1.14 | 1.07 | +6.5% |
| Mar 2026 | 7 May 2026 | 1.29 | 1.28 | +0.8% |
| Dec 2025 | 5 Feb 2026 | 1.31 | 1.27 | +3.2% |
| Sep 2025 | 6 Nov 2025 | 1.27 | 1.12 | +13.4% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart HAE
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
9JR John Rogers Ariel Investments | 1.54% |
CA Cliff Asness AQR Capital Management | 0.06% |
RD Ray Dalio Bridgewater Associates | 0.02% |
IE Israel Englander Millennium Management | 0.02% |
JS Jim Simons Renaissance Technologies | 0.01% |
KG Ken Griffin Citadel Advisors | 0.01% |
SC Steven Cohen Point72 Asset Management | 0.01% |
JG Joel Greenblatt Gotham Asset Management | 0% |
Šn Švýcarská národní banka Swiss National Bank | 0% |
Frequently asked questions
How much is Haemonetics Corp Mass (HAE) stock?
Haemonetics Corp Mass shares trade at $119.97, +0.65% over the last trading day. The price is delayed.
What is the market cap of Haemonetics Corp Mass?
The market cap of Haemonetics Corp Mass is about $5.5B and its price-to-earnings ratio (P/E) is 58.
Which big investors hold Haemonetics Corp Mass?
According to the latest 13F filings, 9 of 87 tracked investors hold Haemonetics Corp Mass, for example John Rogers, Cliff Asness, Ray Dalio.
When will Haemonetics Corp Mass report its next results?
The next earnings report of Haemonetics Corp Mass is expected on 5 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.